Search Results - "Simonet, S."
-
1
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
Published in Journal of bone and mineral research (01-12-2010)“…The purpose of this study was to evaluate the effects of sclerostin inhibition by treatment with a sclerostin antibody (Scl‐AbII) on bone formation, bone mass,…”
Get full text
Journal Article -
2
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
Published in Journal of bone and mineral research (01-05-2011)“…Therapeutic enhancement of fracture healing would help to prevent the occurrence of orthopedic complications such as nonunion and revision surgery. Sclerostin…”
Get full text
Journal Article -
3
Gadolinium-Based Nanoparticles Can Overcome the Radioresistance of Head and Neck Squamous Cell Carcinoma Through the Induction of Autophagy
Published in Journal of biomedical nanotechnology (01-01-2020)“…Radiation therapy is a mainstay in the therapeutic management of Head and Neck Squamous Cell Carcinoma (HNSCC). Despite significant progress in this field,…”
Get more information
Journal Article -
4
Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice
Published in Veterinary pathology (01-09-2015)“…Bone structure is modulated by the interaction between receptor activator of nuclear factor–κB (RANK) and RANK ligand (RANKL). Osteoprotegerin (OPG), a decoy…”
Get full text
Journal Article -
5
RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats
Published in Journal of bone and mineral research (01-05-2008)“…Introduction: Ovariectomy (OVX) results in bone loss caused by increased bone resorption. RANKL is an essential mediator of bone resorption. We examined…”
Get full text
Journal Article -
6
-
7
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
Published in Cell (18-04-1997)“…A novel secreted glycoprotein that regulates bone resorption has been identified. The protein, termed Osteoprotegerin (OPG), is a novel member of the TNF…”
Get full text
Journal Article -
8
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial
Published in Chest (01-05-2017)“…Despite Food and Drug Administration approval of 2 new drugs for idiopathic pulmonary fibrosis (IPF), curative therapies remain elusive and mortality remains…”
Get full text
Journal Article -
9
One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength
Published in Journal of bone and mineral research (01-07-2009)“…RANKL is an essential mediator of bone resorption, and its activity is inhibited by osteoprotegerin (OPG). Transgenic (Tg) rats were engineered to continuously…”
Get full text
Journal Article -
10
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
Published in Genes & development (01-05-1998)Get full text
Journal Article -
11
Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats
Published in The Journal of clinical investigation (01-10-1995)“…Alveolar type II cell proliferation occurs after many forms of lung injury and is thought to play a critical role in alveolar epithelial repair. Keratinocyte…”
Get full text
Journal Article -
12
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock‐In Mice That Express Chimeric (Murine/Human) RANKL
Published in Journal of bone and mineral research (01-02-2009)“…RANKL is a TNF family member that mediates osteoclast formation, activation, and survival by activating RANK. The proresorptive effects of RANKL are prevented…”
Get full text
Journal Article -
13
Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody
Published in Endocrinology (Philadelphia) (01-12-2014)“…The effects of up to 26 weeks of sclerostin antibody (Scl-Ab) treatment were investigated in ovariectomized (OVX) rats. Two months after surgery, 6-month-old…”
Get full text
Journal Article -
14
P10.03: Evaluation of Arterial Stiffness in Atherosclerotic Rabbits in Vivo Via Echotracking
Published in Artery research (2011)“…Objectives We have shown that large artery stiffening, a major risk factor in cardiovascular diseases, can be evaluated in hypertensive rats by echotracking,…”
Get full text
Journal Article -
15
A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice
Published in The Journal of biological chemistry (15-04-1993)“…The human apolipoprotein (apo) E and apoC-I genes are located 5 kilobases apart in the same transcriptional orientation on chromosome 19, and they are…”
Get full text
Journal Article -
16
Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
Published in Endocrinology (Philadelphia) (01-09-2011)“…Clinical studies have revealed a blunting of the bone anabolic effects of parathyroid hormone treatment in osteoporotic patients in the setting of pre- or…”
Get full text
Journal Article -
17
Keratinocyte growth factor reduces lung damage due to acid instillation in rats
Published in American journal of respiratory cell and molecular biology (01-10-1996)“…Acid aspiration is a serious complication of anesthesia and other forms of unconsciousness that can result in the adult respiratory distress syndrome (ARDS),…”
Get more information
Journal Article -
18
Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
Published in The Journal of biological chemistry (21-01-1994)“…Overexpression of human apolipoprotein (apo) C-III in the plasma of transgenic mice results in hypertriglyceridemia, with up to a 20-fold elevation in plasma…”
Get full text
Journal Article -
19
Osteoclast differentiation and activation
Published in Nature (London) (15-05-2003)“…Osteoclasts are specialized cells derived from the monocyte/macrophage haematopoietic lineage that develop and adhere to bone matrix, then secrete acid and…”
Get full text
Journal Article -
20
Pulmonary Malformation in Transgenic Mice Expressing Human Keratinocyte Growth Factor in the Lung
Published in Proceedings of the National Academy of Sciences - PNAS (19-12-1995)“…Expression of human keratinocyte growth factor (KGF/FGF-7) was directed to epithelial cells of the developing embryonic lung of transgenic mice disrupting…”
Get full text
Journal Article